Phase 2 study of axitinib + nivolumab in mucosal melanoma with pilot addition of stereotactic body radiotherapy or ipilimumab in select progressors.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Sarah E. Lochrin, Hannah L. Kalvin, Monica F. Chen, James William Smithy, Parisa Momtaz, Michael A. Postow, Shirlanna Station, Amanda J. Hill, Charlene Garcia Hochreiter, Roseann Durak, Katherine Panageas, Randy Yeh, Christopher A. Barker, Alexander Noor Shoushtari
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410818619